about
Identification of virulence determinants in influenza virusesVerdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.Polymerase discordance in novel swine influenza H3N2v constellations is tolerated in swine but not human respiratory epithelial cellsIn ovo and in vitro susceptibility of American alligators (Alligator mississippiensis) to avian influenza virus infection.Memory T cells generated by prior exposure to influenza cross react with the novel H7N9 influenza virus and confer protective heterosubtypic immunity.Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 ExpressionComparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1).Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice.Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection.Virus-vectored influenza virus vaccines.Low pathogenic avian influenza isolates from wild birds replicate and transmit via contact in ferrets without prior adaptation.Protection against lethal influenza virus challenge by RNA interference in vivo.Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading.Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infectionIdentification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice.Antiviral responses by Swine primary bronchoepithelial cells are limited compared to human bronchoepithelial cells following influenza virus infection.Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection.Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challengeBat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment.Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge.Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicitysiRNA Genome Screening Approaches to Therapeutic Drug Repositioning.Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig modelGene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).Animal models for evaluation of influenza vaccines.Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targetsIndoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge.Potential directions for chicken immunology research.Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication.Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B- and T-Cell lymphomas.One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles.Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.Adenovirus 36, adiposity, and bone strength in late-adolescent females.Passage of low-pathogenic avian influenza (LPAI) viruses mediates rapid genetic adaptation of a wild-bird isolate in poultry.Influenza Research & Development - GTCBio's Third Annual Conference (July 9-11 - Boston, Massachusetts, USA, 2014).De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
P50
Q30363692-27DEB346-4765-49E0-B254-1E223C29F117Q30363986-C50B8007-49BD-425F-8118-BAB4E2AE8BFFQ30367947-39633CED-CAEC-410C-9073-FED94F1DD26FQ30368506-15710A6E-8A57-47F2-B5D5-2402AA1DB4E3Q30371653-9D798235-9E4A-4664-A076-0A8594E02B68Q30372625-6C4827BC-00D4-46B6-99A1-30B87F9E3B1AQ30400180-43F1EC13-4CD7-4F8B-A5D9-8CACB4A3D2ACQ30429302-118213B4-93D7-426A-AA3A-213FB3B8E3B6Q34066721-26D01C82-A605-403D-8494-A241B9634DABQ34102268-AA88AA01-9049-4F30-81C5-D27B220D22EFQ34295681-4B02C243-6638-4223-8869-D1500AE01EC6Q34514565-73069D6B-6976-489D-AFC5-D3BA0F80A3D5Q34646878-D585AA77-2758-4284-88BF-FA1F5EAB776CQ34735848-4F55EBB6-C444-45A4-AE25-D62079AFC6F5Q34778943-4AF6C1B7-082A-4852-B3F7-54FA7F7B3862Q34785589-BD29A3AF-3F88-4E04-BBCA-F60ACE173684Q34789319-ABBA328A-B9BF-40AE-8480-8AC19BA11498Q34854966-A59B62B4-0649-4DF6-8206-DDBD93E10687Q35214413-54338F77-476F-403E-BB17-FABC139D25AFQ35865362-59313DFA-0D86-4FDB-A447-CC1F7FE51947Q36016500-043C0DE6-EB0B-4935-830E-7918CB89A75CQ36251680-0DCED0D7-5137-45A8-BC01-25A8C4B670FAQ36506905-C2098E53-D5A1-4C3B-9C61-81EBF6F2293AQ36540164-CF842096-1B10-4602-804F-64740BAECE1CQ37277365-C9D2D15B-70D5-4A28-97F3-EBE637361B3AQ37302777-163441A3-6B05-4A3C-A5CD-B14DF2E6812BQ37547355-44674492-DD21-47C2-A7DB-274A2763137AQ37586844-F63FD0EA-4151-4D5A-B18F-881BC0970CE8Q37600679-624D3830-B912-47B4-99A1-171EB8E8E5D3Q37698939-FCEAC066-46C1-4951-B831-1511E3C0679DQ37715931-C5E0B4C2-6102-46CF-AD88-49B203331B26Q38109446-68689850-965D-418B-A62D-A4BA81C848C0Q39297218-D4E7284A-6DEB-48D5-A294-948C80C761D6Q39475560-BB271981-E893-494C-9810-DF94BD28543AQ39525904-B040156F-3471-47D0-938F-F0E8217FD1D0Q41933365-7241972C-5C63-408E-9F7F-239D98CD859EQ44067398-2283B30C-75A9-420D-ABF1-12B5ED3AD3DBQ44514129-66C86E88-8783-40E6-980B-87B2C16AE1A3Q51256036-B8A91E87-788E-4351-9003-4A8240669DD5Q53974447-9404DBFF-5C1D-4CC4-A786-B7FC049F283B
P50
description
researcher ORCID ID = 0000-0002-1523-5588
@en
wetenschapper
@nl
name
Stephen M Tompkins
@ast
Stephen M Tompkins
@en
Stephen M Tompkins
@nl
type
label
Stephen M Tompkins
@ast
Stephen M Tompkins
@en
Stephen M Tompkins
@nl
prefLabel
Stephen M Tompkins
@ast
Stephen M Tompkins
@en
Stephen M Tompkins
@nl
P106
P31
P496
0000-0002-1523-5588